abbott medical u.k. limited
abbott medical u.k. limited Company Information
Company Number
02423907
Website
www.abbott.comRegistered Address
elder house central boulevard, blythe valley business park, solihull, B90 8AJ
Industry
Other human health activities
Telephone
01213060500
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
abbott laboratoreis limited 100%
abbott medical u.k. limited Estimated Valuation
The estimated valuation range for abbott medical u.k. limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £68m to £153.8m
abbott medical u.k. limited Estimated Valuation
The estimated valuation range for abbott medical u.k. limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £68m to £153.8m
abbott medical u.k. limited Estimated Valuation
The estimated valuation range for abbott medical u.k. limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £68m to £153.8m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Abbott Medical U.k. Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Abbott Medical U.k. Limited Overview
Abbott Medical U.k. Limited is a live company located in solihull, B90 8AJ with a Companies House number of 02423907. It operates in the other human health activities sector, SIC Code 86900. Founded in September 1989, it's largest shareholder is abbott laboratoreis limited with a 100% stake. Abbott Medical U.k. Limited is a mature, mega sized company, Pomanda has estimated its turnover at £161m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Abbott Medical U.k. Limited Health Check
Pomanda's financial health check has awarded Abbott Medical U.K. Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 9 areas for improvement. Company Health Check FAQs
3 Strong
0 Regular
9 Weak
Size
annual sales of £161m, make it larger than the average company (£843k)
£161m - Abbott Medical U.k. Limited
£843k - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (4.7%)
4% - Abbott Medical U.k. Limited
4.7% - Industry AVG
Production
with a gross margin of 24.1%, this company has a higher cost of product (34.8%)
24.1% - Abbott Medical U.k. Limited
34.8% - Industry AVG
Profitability
an operating margin of 4% make it less profitable than the average company (7.4%)
4% - Abbott Medical U.k. Limited
7.4% - Industry AVG
Employees
with 264 employees, this is above the industry average (20)
264 - Abbott Medical U.k. Limited
20 - Industry AVG
Pay Structure
on an average salary of £100.3k, the company has a higher pay structure (£24.6k)
£100.3k - Abbott Medical U.k. Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £609.8k, this is more efficient (£48k)
£609.8k - Abbott Medical U.k. Limited
£48k - Industry AVG
Debtor Days
it gets paid by customers after 65 days, this is later than average (23 days)
65 days - Abbott Medical U.k. Limited
23 days - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (16 days)
5 days - Abbott Medical U.k. Limited
16 days - Industry AVG
Stock Days
it holds stock equivalent to 39 days, this is more than average (9 days)
39 days - Abbott Medical U.k. Limited
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (109 weeks)
2 weeks - Abbott Medical U.k. Limited
109 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 41.5%, this is a higher level of debt than the average (26%)
41.5% - Abbott Medical U.k. Limited
26% - Industry AVG
abbott medical u.k. limited Credit Report and Business Information
Abbott Medical U.k. Limited Competitor Analysis
Perform a competitor analysis for abbott medical u.k. limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
abbott medical u.k. limited Ownership
ABBOTT MEDICAL U.K. LIMITED group structure
Abbott Medical U.K. Limited has no subsidiary companies.
Ultimate parent company
ABBOTT HOLDINGS UNIVERSAL LTD
#0130259
2 parents
ABBOTT MEDICAL U.K. LIMITED
02423907
abbott medical u.k. limited directors
Abbott Medical U.K. Limited currently has 3 directors. The longest serving directors include Mr Ross Campbell (Feb 2020) and Mr Matt Scrivener (May 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Ross Campbell | United Kingdom | 48 years | Feb 2020 | - | Director |
| Mr Matt Scrivener | England | 43 years | May 2023 | - | Director |
| Mrs Alison Davies | United Kingdom | 56 years | Oct 2023 | - | Director |
ABBOTT MEDICAL U.K. LIMITED financials
Abbott Medical U.K. Limited's latest turnover from December 2022 is £161 million and the company has net assets of £62.2 million. According to their latest financial statements, Abbott Medical U.K. Limited has 264 employees and maintains cash reserves of £2.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 160,976,000 | 150,535,000 | 127,646,000 | 145,100,000 | 94,561,000 | 32,191,756 | 26,313,065 | 25,744,612 | 23,312,930 | 21,019,667 | 23,603,773 | 24,402,028 | 23,083,664 | 20,905,497 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Cost Of Sales | 122,140,000 | 111,616,000 | 90,435,000 | 106,291,000 | 68,929,000 | 0 | ||||||||
| Gross Profit | 38,836,000 | 38,919,000 | 37,211,000 | 38,809,000 | 25,632,000 | 32,191,756 | ||||||||
| Admin Expenses | 32,420,000 | 33,688,000 | 34,153,000 | 35,359,000 | 22,636,000 | 26,756,777 | ||||||||
| Operating Profit | 6,416,000 | 5,231,000 | 3,058,000 | 3,450,000 | 2,996,000 | 5,434,979 | 2,724,633 | 4,461,936 | 4,439,840 | 6,178,698 | 3,195,696 | 6,913,602 | 4,023,495 | 4,091,076 |
| Interest Payable | 64,000 | 80,000 | 18,000 | 105,000 | 28,000 | 0 | 2,627 | 4,863 | 1,908 | 0 | 54,598 | 39,832 | 887 | 7,410 |
| Interest Receivable | 624,000 | 49,000 | 101,000 | 286,000 | 488,000 | 505,782 | 469,956 | 498,276 | 463,545 | 40,728 | 29,697 | 85,618 | 36,925 | 5,960 |
| Pre-Tax Profit | 6,976,000 | 5,200,000 | 3,141,000 | 3,631,000 | 3,456,000 | 5,940,761 | 3,563,539 | 4,955,349 | 4,901,477 | 6,219,426 | 3,170,795 | 6,959,388 | 4,059,533 | 4,089,626 |
| Tax | -1,708,000 | -1,643,000 | 1,342,000 | 1,457,000 | -1,015,000 | -2,170,258 | -784,221 | -1,049,253 | -938,924 | -1,418,868 | -830,546 | -2,163,313 | -1,295,320 | -1,128,232 |
| Profit After Tax | 5,268,000 | 3,557,000 | 4,483,000 | 5,088,000 | 2,441,000 | 3,770,503 | 2,779,318 | 3,906,096 | 3,962,553 | 4,800,558 | 2,340,249 | 4,796,075 | 2,764,213 | 2,961,394 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 5,268,000 | 3,557,000 | 4,483,000 | 5,088,000 | 2,441,000 | 3,770,503 | 2,779,318 | 3,906,096 | 3,962,553 | 4,800,558 | 2,340,249 | 4,796,075 | 2,764,213 | 2,961,394 |
| Employee Costs | 26,476,000 | 23,752,000 | 22,962,000 | 24,040,000 | 12,753,000 | 13,270,142 | 14,214,271 | 13,484,531 | 11,103,861 | 10,429,322 | 11,634,261 | 10,819,195 | 9,929,018 | 8,517,443 |
| Number Of Employees | 264 | 253 | 249 | 239 | 163 | 175 | 175 | 159 | 140 | 141 | 135 | 134 | 130 | 129 |
| EBITDA* | 8,722,000 | 7,615,000 | 4,561,000 | 5,373,000 | 4,446,000 | 5,549,522 | 2,813,202 | 4,543,690 | 4,539,467 | 6,303,554 | 4,791,044 | 6,996,946 | 4,098,453 | 4,193,305 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 5,369,000 | 5,946,000 | 2,160,000 | 2,674,000 | 3,195,000 | 375,118 | 124,650 | 131,253 | 125,047 | 154,461 | 226,947 | 139,887 | 94,946 | 147,260 |
| Intangible Assets | 966,000 | 966,000 | 966,000 | 1,124,000 | 379,000 | 407,916 | 437,053 | 466,190 | 495,327 | 524,464 | 553,601 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,624,123 | 3,624,123 | 0 | 0 | 1,421,545 | 0 | 0 |
| Debtors (Due After 1 year) | 1,081,000 | 1,017,000 | 727,000 | 420,000 | 0 | 22,395,500 | 22,395,500 | 22,395,500 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 7,416,000 | 7,929,000 | 3,853,000 | 4,218,000 | 3,574,000 | 23,178,534 | 22,957,203 | 26,617,066 | 4,244,497 | 678,925 | 780,548 | 1,561,432 | 94,946 | 147,260 |
| Stock & work in progress | 13,327,000 | 12,650,000 | 16,216,000 | 29,406,000 | 11,075,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 28,758,000 | 23,448,000 | 19,810,000 | 24,939,000 | 18,834,000 | 25,793,174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 52,589,000 | 46,888,000 | 42,359,000 | 23,252,000 | 22,857,000 | 5,782,369 | 14,969,179 | 12,016,167 | 27,868,122 | 26,750,937 | 21,196,481 | 20,354,282 | 10,199,243 | 5,114,902 |
| Misc Debtors | 2,066,000 | 1,657,000 | 2,295,000 | 3,402,000 | 85,000 | 101,341 | 350,543 | 432,343 | 151,747 | 258,111 | 345,949 | 438,021 | 3,464,144 | 3,765,699 |
| Cash | 2,073,000 | 2,688,000 | 2,104,000 | 6,783,000 | 3,095,000 | 2,421,133 | 2,500,280 | 0 | 0 | 0 | 0 | 41,134 | 0 | 207,204 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 98,813,000 | 87,331,000 | 82,784,000 | 87,782,000 | 55,946,000 | 34,098,017 | 17,820,002 | 12,448,510 | 28,019,869 | 27,009,048 | 21,542,430 | 20,833,437 | 13,663,387 | 9,087,805 |
| total assets | 106,229,000 | 95,260,000 | 86,637,000 | 92,000,000 | 59,520,000 | 57,276,551 | 40,777,205 | 39,065,576 | 32,264,366 | 27,687,973 | 22,322,978 | 22,394,869 | 13,758,333 | 9,235,065 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,718 | 94,213 | 369,555 | 10,245 | 0 | 63,485 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,798,000 | 1,343,000 | 1,227,000 | 2,386,000 | 895,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 17,124,000 | 10,838,000 | 13,935,000 | 23,781,000 | 11,060,000 | 5,531,661 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 1,034,000 | 920,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 21,616,000 | 22,593,000 | 17,857,000 | 17,578,000 | 9,554,000 | 16,045,808 | 9,640,349 | 10,696,781 | 7,385,961 | 5,997,273 | 5,418,795 | 8,027,069 | 4,081,881 | 2,392,280 |
| total current liabilities | 41,572,000 | 35,694,000 | 33,019,000 | 43,745,000 | 21,509,000 | 21,577,469 | 9,640,349 | 10,708,499 | 7,480,174 | 6,366,828 | 5,429,040 | 8,027,069 | 4,145,366 | 2,392,280 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 1,776,000 | 2,075,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 405,000 | 325,000 | 325,000 | 0 | 321,000 | 841,436 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 318,000 | 276,000 | 0 | 0 | 284,000 | 24,073 | 53,033 | 35,778 | 88,153 | 75,214 | 7,283 | 4,057 | 35,336 | 33,381 |
| total long term liabilities | 2,499,000 | 2,676,000 | 325,000 | 0 | 605,000 | 865,509 | 53,033 | 35,778 | 88,153 | 75,214 | 7,283 | 4,057 | 35,336 | 33,381 |
| total liabilities | 44,071,000 | 38,370,000 | 33,344,000 | 43,745,000 | 22,114,000 | 22,442,978 | 9,693,382 | 10,744,277 | 7,568,327 | 6,442,042 | 5,436,323 | 8,031,126 | 4,180,702 | 2,425,661 |
| net assets | 62,158,000 | 56,890,000 | 53,293,000 | 48,255,000 | 37,406,000 | 34,833,573 | 31,083,823 | 28,321,299 | 24,696,039 | 21,245,931 | 16,886,655 | 14,363,743 | 9,577,631 | 6,809,404 |
| total shareholders funds | 62,158,000 | 56,890,000 | 53,293,000 | 48,255,000 | 37,406,000 | 34,833,573 | 31,083,823 | 28,321,299 | 24,696,039 | 21,245,931 | 16,886,655 | 14,363,743 | 9,577,631 | 6,809,404 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 6,416,000 | 5,231,000 | 3,058,000 | 3,450,000 | 2,996,000 | 5,434,979 | 2,724,633 | 4,461,936 | 4,439,840 | 6,178,698 | 3,195,696 | 6,913,602 | 4,023,495 | 4,091,076 |
| Depreciation | 2,306,000 | 2,384,000 | 1,345,000 | 1,765,000 | 1,421,000 | 85,406 | 59,432 | 52,617 | 70,490 | 95,719 | 94,544 | 83,344 | 74,958 | 102,229 |
| Amortisation | 0 | 0 | 158,000 | 158,000 | 29,000 | 29,137 | 29,137 | 29,137 | 29,137 | 29,137 | 1,500,804 | 0 | 0 | 0 |
| Tax | -1,708,000 | -1,643,000 | 1,342,000 | 1,457,000 | -1,015,000 | -2,170,258 | -784,221 | -1,049,253 | -938,924 | -1,418,868 | -830,546 | -2,163,313 | -1,295,320 | -1,128,232 |
| Stock | 677,000 | -3,566,000 | -13,190,000 | 18,331,000 | 11,075,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 11,484,000 | 7,819,000 | 13,178,000 | 10,237,000 | -12,296,384 | 16,357,162 | 2,871,212 | 6,824,141 | 1,010,821 | 5,466,618 | 750,127 | 7,128,916 | 4,782,786 | 8,880,601 |
| Creditors | 455,000 | 116,000 | -1,159,000 | 1,491,000 | 895,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -977,000 | 4,736,000 | 279,000 | 8,024,000 | -6,491,808 | 6,405,459 | -1,056,432 | 3,310,820 | 1,388,688 | 578,478 | -2,608,274 | 3,945,188 | 1,689,601 | 2,392,280 |
| Deferred Taxes & Provisions | 42,000 | 276,000 | 0 | -284,000 | 259,927 | -28,960 | 17,255 | -52,375 | 12,939 | 67,931 | 3,226 | -31,279 | 1,955 | 33,381 |
| Cash flow from operations | -5,627,000 | 6,847,000 | 5,035,000 | -12,507,000 | -684,497 | -6,601,399 | -1,881,408 | -71,259 | 3,991,349 | 64,477 | 605,323 | 1,618,626 | -288,097 | -3,389,867 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | -3,624,123 | 0 | 3,624,123 | 0 | -1,421,545 | 1,421,545 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 6,286,000 | -3,097,000 | -9,846,000 | 12,721,000 | 5,528,339 | 5,531,661 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -185,000 | 2,995,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 80,000 | 0 | 325,000 | -321,000 | -520,436 | 841,436 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 560,000 | -31,000 | 83,000 | 181,000 | 460,000 | 505,782 | 467,329 | 493,413 | 461,637 | 40,728 | -24,901 | 45,786 | 36,038 | -1,450 |
| cash flow from financing | 6,741,000 | -93,000 | -8,883,000 | 18,342,000 | 5,599,330 | 6,858,126 | 450,535 | 212,577 | -50,808 | -400,554 | 157,762 | 35,823 | 40,052 | 3,846,560 |
| cash and cash equivalents | ||||||||||||||
| cash | -615,000 | 584,000 | -4,679,000 | 3,688,000 | 673,867 | -79,147 | 2,500,280 | 0 | 0 | 0 | -41,134 | 41,134 | -207,204 | 207,204 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -11,718 | -82,495 | -275,342 | 359,310 | 10,245 | -63,485 | 63,485 | 0 |
| change in cash | -615,000 | 584,000 | -4,679,000 | 3,688,000 | 673,867 | -79,147 | 2,511,998 | 82,495 | 275,342 | -359,310 | -51,379 | 104,619 | -270,689 | 207,204 |
P&L
December 2022turnover
161m
+7%
operating profit
6.4m
+23%
gross margin
24.2%
-6.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
62.2m
+0.09%
total assets
106.2m
+0.12%
cash
2.1m
-0.23%
net assets
Total assets minus all liabilities
abbott medical u.k. limited company details
company number
02423907
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
September 1989
age
35
accounts
Full Accounts
ultimate parent company
previous names
st. jude medical u.k. limited (February 2018)
freelake limited (October 1989)
incorporated
UK
address
elder house central boulevard, blythe valley business park, solihull, B90 8AJ
last accounts submitted
December 2022
abbott medical u.k. limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to abbott medical u.k. limited.
abbott medical u.k. limited Companies House Filings - See Documents
| date | description | view/download |
|---|
